Can Epicatechin Help Long COVID Fatigue? New Clinical Trial on Inflammation and Cellular Energy

Persistent fatigue is one of the most debilitating symptoms reported after COVID-19 infection. For many individuals, the exhaustion is not simply “feeling tired.” It is a profound reduction in functional capacity, including difficulty sustaining physical activity, impaired concentration, and reduced quality of life that can last for months.

But what if something deeper going on, something at the cellular level?

A 2024 randomized, double-blind, placebo-controlled clinical trial published in the Journal of Clinical Medicine (Munguía et al., 2026) explored exactly this hypothesis in people with long COVID and chronic fatigue. The researchers tested whether a cacao-flavonoid supplement enriched with (−)-epicatechin could improve fatigue-related outcomes and associated biological markers, compared with placebo.

Here is what the research found.

Understanding Long COVID Fatigue

Long COVID is associated with a complex constellation of symptoms, but chronic fatigue remains one of the most common and disabling. Emerging evidence suggests that several interconnected mechanisms may be involved:

• Persistent low-grade inflammation
• Endothelial dysfunction (impaired vascular lining function)
• Possible mitochondrial stress or reduced cellular energy capacity

Inflammation consumes metabolic resources. Endothelial dysfunction can impair oxygen and nutrient delivery to tissues. When these systems are compromised, the body’s ability to generate and distribute energy efficiently may be reduced.

This clinical trial was designed to test whether modulating inflammation and vascular health through supplementation with (−)-epicatechin could influence fatigue outcomes.

Study Overview: What Was Done

The study enrolled 46 participants diagnosed with long COVID and persistent chronic fatigue. Participants were randomized to receive either:

• An epicatechin-enriched cacao flavonoid supplement (two capsules per day), or
• A placebo

The intervention lasted 90 days.

Importantly, this was a randomized, double-blind, placebo-controlled trial. This is the gold standard for evaluating clinical interventions. Neither the participants nor the researchers knew who was receiving the supplement or placebo until after the study concluded.

Researchers evaluated several outcomes:

• Fatigue severity
• Quality of life
• Handgrip strength
• Inflammatory cytokines (IL-1β, IL-6, TNF-α)
• Syndecan-1, a marker associated with endothelial glycocalyx damage

This design allowed the team to assess both subjective symptoms and objective biological markers.

Key Findings

1. Reduction in Fatigue

Participants receiving the epicatechin-enriched supplement experienced a statistically significant reduction in fatigue scores compared to baseline. The placebo group did not demonstrate a comparable change.

This suggests that targeting underlying biological pathways may influence symptom burden.

2. Improvement in Quality of Life

Quality of life scores improved significantly in the supplement group. Improvements in quality of life are particularly meaningful in chronic conditions, as they reflect real-world functional impact.

3. Increased Handgrip Strength

Handgrip strength increased in participants taking the supplement. Grip strength is widely used in clinical research as a proxy for overall functional capacity and physiological resilience.

Improvements here suggest that the intervention may have influenced not only perceived fatigue but also measurable physical performance.

4. Decreases in Inflammatory Markers

The study reported reductions in key inflammatory cytokines:

• Interleukin-1β (IL-1β)
• Interleukin-6 (IL-6)
• Tumor Necrosis Factor-alpha (TNF-α)

These molecules play central roles in immune signaling and systemic inflammation. Persistent elevation has been associated with fatigue and post-viral syndromes.

5. Reduction in Syndecan-1

Syndecan-1 is a marker associated with endothelial glycocalyx damage. The glycocalyx is a protective layer lining blood vessels that plays a crucial role in vascular integrity and microcirculatory function.

A reduction in syndecan-1 suggests potential improvement in endothelial health.

Connecting the Dots: Inflammation, Endothelium, and Energy

Fatigue is often discussed symptomatically but rarely mechanistically. In other words, what biological processes are causing it.

This study supports a systems-based perspective:

• Inflammation is metabolically expensive. Chronic immune activation diverts energy resources.
• Endothelial dysfunction can impair tissue oxygenation and nutrient delivery.
• Mitochondrial efficiency may decline in inflammatory states.

Together, these disruptions may reduce effective energy availability at the cellular level.

(−)-Epicatechin, a flavanol found in cacao and other plants, has been studied for its potential effects on endothelial function, nitric oxide signaling, and mitochondrial biogenesis pathways in preclinical and human studies. While the current trial does not directly measure mitochondrial function, the combination of reduced inflammation, improved endothelial markers, and enhanced functional strength suggests a broader improvement in physiological efficiency.

The findings align with the hypothesis that persistent fatigue may reflect compromised energy capacity rather than simply psychological exhaustion.

Important Limitations of the Study

Scientific credibility requires clarity about limitations.

• The sample size was relatively small (46 participants).
• The study was conducted at a single center.
• Biomarker changes, while promising, require replication in larger populations.
• The trial duration was 90 days; long-term effects remain unknown.

This study contributes to an evolving evidence base but does not establish definitive clinical guidelines.

Practical Takeaways

For individuals experiencing persistent post-viral fatigue:

1. Fatigue may have measurable biological correlates not just subjective symptoms.
2. Inflammation and vascular function appear to be relevant targets of investigation.
3. Objective measures like grip strength can provide meaningful insight into functional recovery.
4. Nutritional bioactives such as epicatechin can serve as potential adjunctive strategies.

The Bigger Picture

Long COVID has challenged traditional medical frameworks because it sits at the intersection of immunology, vascular biology, and metabolism.

This clinical trial contributes to a growing body of literature suggesting that persistent fatigue may be linked to disruptions in inflammation and endothelial integrity, both of which influence cellular energy systems.

As research continues, a clearer picture is emerging. Supporting systemic physiology may be key to restoring functional capacity. Understanding fatigue through the lens of energy biology expands treatment possibilities.

At Mitozz, we focus on supporting the biological systems that help the body produce and maintain energy at the cellular level. If you’re interested in learning more about how you can support your cellular energy, read our guide How to Repair and Maintain Mitochondrial Health Naturally.

Understanding mitochondrial health is a long-term process and that’s why we created the Mitozz Community. It’s is a free space to explore the science of cellular energy, learn how lifestyle signals support mitochondria, and stay informed through expert discussions, educational content, and live Q&A—at your own pace.

This article summarizes findings from a peer-reviewed clinical study published in the Journal of Clinical Medicine. It is intended for educational purposes only and does not constitute medical advice. Supplements are not intended to diagnose, treat, cure, or prevent any disease. If you are considering taking a supplement, consult healthcare professionals before beginning any supplement regimen, particularly when managing complex post-viral conditions.